A clinical trial at OHSU and UC San Francisco points the way to potential targeted therapies. The drug enzalutamide is a mainstay of treatment for men with life-threatening prostate cancer that has...
A clinical trial at OHSU and UC San Francisco points the way to potential targeted therapies. The drug enzalutamide is a mainstay of treatment for men with life-threatening prostate cancer that has...
Restoring tumor-specific immunity is a treatment strategy that has worked well, but only against some cancers. Research led by OHSU oncologist Julie Graff, M.D., revived hope that the approach may...
At the recent European Society for Medical Oncology meeting, OHSU oncologist Julie Graff, M.D., presented the first evidence of meaningful clinical activity for PD-1 blockade in men with...